In our exploratory evaluation of patients with CSF t-tau >1250 pg/mL, values of the t-tau/p-tau ratio in AD patients were apparently lower than in inflammatory and vascular encephalopathies. This evidence concerns the gene MAPT and Alzheimer disease.